{"success":true,"data":{"pressRelease":{"id":"156935","rtpr_id":"nPn8lL9tWa-20260930","ticker":"TVTX","exchange":"NASDAQ","all_tickers":["TVTX"],"title":"Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm","author":"PR Newswire","published_at":"2026-09-30T13:58:00.023Z","article_body":"Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm\nPR Newswire\n\nNEW YORK, Sept. 30, 2026\n\nNEW YORK, Sept. 30, 2026/PRNewswire/ -- Kuehn Law, PLLC, a shareholder\nlitigation law firm, is investigating whether certain officers and directors\nof Travere Therapeutics, Inc. (NASDAQ: TVTX) breached their fiduciary duties\nto shareholders. The investigation concerns potential self-dealing.\nShareholders may be entitled to damages and corporate governance reforms.\n\nIf you are a long-term TVTX stockholder please contact Justin Kuehn, Esq. by\nemail at justin@kuehn.law (mailto:justin@kuehn.law)  or call (833)\n672-0814. The consultation and case are free with no obligation to you.Kuehn\nLaw pays all case costs and does not charge its investor\nclients. Shareholders should contact the firm immediately as there may be\nlimited time to enforce your rights.\n\nWhy Your Participation Matters:\n\nAs a shareholder your voice matters, and by getting involved, you contribute\nto the integrity and fairness of the financial markets. Your investment. Your\nvoice. Your future.™\n\nFor additional information, please visit Shareholder Derivative Litigation -\nKuehn Law\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4785995-1&h=3194378433&u=https%3A%2F%2Fwww.kuehn.law%2Fservices%2Fshareholder-derivative-litigation&a=Shareholder+Derivative+Litigation+-+Kuehn+Law)\n.\n\nAttorney advertising. Prior results do not guarantee similar outcomes.\n\nContacts:\nKuehn Law, PLLC\nJustin Kuehn, Esq.\n53 Hill Street, Suite 605\nSouthampton, NY 11968\njustin@kuehn.law (mailto:justin@kuehn.law)\n(833) 672-0814\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-travere-therapeutics-inc-to-contact-law-firm-302893828.html\n(https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-travere-therapeutics-inc-to-contact-law-firm-302893828.html)\n\nSOURCE Kuehn Law, PLLC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1515514/Kuehn-Law-PLLC.jpg?id=OA2978223\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn8lL9tWa-20260930","title":"Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm","author":"PR Newswire","ticker":"TVTX","created":"2026-09-30T13:58:00.023Z","tickers":["TVTX"],"exchange":"NASDAQ","article_body":"Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm\nPR Newswire\n\nNEW YORK, Sept. 30, 2026\n\nNEW YORK, Sept. 30, 2026/PRNewswire/ -- Kuehn Law, PLLC, a shareholder\nlitigation law firm, is investigating whether certain officers and directors\nof Travere Therapeutics, Inc. (NASDAQ: TVTX) breached their fiduciary duties\nto shareholders. The investigation concerns potential self-dealing.\nShareholders may be entitled to damages and corporate governance reforms.\n\nIf you are a long-term TVTX stockholder please contact Justin Kuehn, Esq. by\nemail at justin@kuehn.law (mailto:justin@kuehn.law)  or call (833)\n672-0814. The consultation and case are free with no obligation to you.Kuehn\nLaw pays all case costs and does not charge its investor\nclients. Shareholders should contact the firm immediately as there may be\nlimited time to enforce your rights.\n\nWhy Your Participation Matters:\n\nAs a shareholder your voice matters, and by getting involved, you contribute\nto the integrity and fairness of the financial markets. Your investment. Your\nvoice. Your future.™\n\nFor additional information, please visit Shareholder Derivative Litigation -\nKuehn Law\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4785995-1&h=3194378433&u=https%3A%2F%2Fwww.kuehn.law%2Fservices%2Fshareholder-derivative-litigation&a=Shareholder+Derivative+Litigation+-+Kuehn+Law)\n.\n\nAttorney advertising. Prior results do not guarantee similar outcomes.\n\nContacts:\nKuehn Law, PLLC\nJustin Kuehn, Esq.\n53 Hill Street, Suite 605\nSouthampton, NY 11968\njustin@kuehn.law (mailto:justin@kuehn.law)\n(833) 672-0814\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-travere-therapeutics-inc-to-contact-law-firm-302893828.html\n(https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-travere-therapeutics-inc-to-contact-law-firm-302893828.html)\n\nSOURCE Kuehn Law, PLLC\n\n\n\nPhoto: \nhttps://mmx.prnewswire.com/media/MS1515514/Kuehn-Law-PLLC.jpg?id=OA2978223\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-09-30T13:58:00.072559845Z","server_sent_at_ms":1790776680072},"received_at":"2026-09-30T13:58:00.124Z","source_url":"https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-travere-therapeutics-inc-to-contact-law-firm-302893828.html"},"analysis":{"id":"145611","press_release_id":"156935","analysis_json":{"industry":{"label":"Pharmaceuticals","sector":"Health Care"},"redFlags":["derivative-suit investigation alleges potential officer/director self-dealing at TVTX"],"eventType":"legal_litigation","narrative":"Kuehn Law, a shareholder litigation firm, announced it is investigating whether certain officers and directors of Travere Therapeutics breached fiduciary duties through potential self-dealing.\n\nThe release solicits long-term TVTX stockholders to contact the firm about a possible derivative action, with free consultations and no obligation.\n\nThis is law-firm solicitation rather than an issuer disclosure or court action; no claims have been filed or certified.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm derivative-suit solicitation -- suppress."},"keyFigures":{},"namedEntities":{"people":[{"name":"Justin Kuehn, Esq.","role":"attorney, Kuehn Law"}],"products":[],"companies":[{"name":"Travere Therapeutics, Inc.","ticker":"TVTX","relationship":"investigation target"},{"name":"Kuehn Law, PLLC","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by Kuehn Law investigating potential fiduciary breaches at TVTX. No issuer disclosure, no filed lawsuit or certified class — pure law-firm marketing."},"tickerRelevance":{"others":[],"primary":"TVTX"},"globalImportance":10,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Kuehn Law, a shareholder litigation firm, announced it is investigating whether certain officers and directors of Travere Therapeutics breached fiduciary duties through potential self-dealing.\n\nThe release solicits long-term TVTX stockholders to contact the firm about a possible derivative action, with free consultations and no obligation.\n\nThis is law-firm solicitation rather than an issuer disclosure or court action; no claims have been filed or certified.","key_figures":{},"named_entities":{"people":[{"name":"Justin Kuehn, Esq.","role":"attorney, Kuehn Law"}],"products":[],"companies":[{"name":"Travere Therapeutics, Inc.","ticker":"TVTX","relationship":"investigation target"},{"name":"Kuehn Law, PLLC","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-09-30T13:58:04.305Z","global_importance":10,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":4165,"modelName":"glm-5.3-flashx"}}